Table 4.
Groups | Heart rate (beats/min) | MAP (mmHg) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | |
Remimazolam group (n = 30) | 78.51 ± 11.53 | 74.1 ± 11.01a | 71.61 ± 9.92a | 70.11 ± 8.91a | 79.52 ± 9.11 | 100.80 ± 10.21 | 73.86 ± 9.59a | 79.41 ± 10.31a | 85.03 ± 11.02a | 99.34 ± 12.03 |
Propofol group (n = 29) | 76.62 ± 9.31 | 65.4 ± 8.11 | 64.63 ± 12.81 | 62.12 ± 7.34 | 70.7 ± 11.41 | 99.41 ± 10.60 | 64.56 ± 8.34 | 70.61 ± 9.52 | 78.41 ± 10.03 | 97.21 ± 11.64 |
F interaction, P interaction | 32.134, < 0.001 | 19.117, < 0.001 | ||||||||
F time-point, P time-point | 21.097, < 0.001 | 13.085, < 0.001 | ||||||||
F between-group, P between-group | 16.319, < 0.001 | 8.349, < 0.001 |
aP < 0.05 vs the propofol group; T0: before anesthesia induction, T1: immediately before laryngeal mask insertion, T2: 5 min after laryngeal mask insertion, T3: 30 min after laryngeal mask insertion, T4: 5 min after laryngeal mask removal